AAM
GRCL

Alpine Associates Management’s Gracell Biotechnologies Inc. American Depositary Shares GRCL Stock Holding History

Alpine Associates Management’s Portfolio GRCL Stock Details GRCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,278,454
Closed -$12.8M – 54
2023
Q4 		$12.8M Buy
+1,278,454
New +$12.8M 0.66% 29